Zhikui Liu Selected Research

p300-CBP-associated factor

1/2018	P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts.
5/2016	PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhikui Liu Research Topics

Disease

31	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 02/2015
30	Neoplasms (Cancer) 01/2022 - 05/2015
10	Neoplasm Metastasis (Metastasis) 12/2021 - 02/2016
6	Carcinogenesis 11/2020 - 01/2017
4	Hypoxia (Hypoxemia) 01/2020 - 01/2017
2	Fibrosis (Cirrhosis) 11/2020 - 09/2018
2	Breast Neoplasms (Breast Cancer) 10/2017 - 12/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2020
1	Down Syndrome Critical Region 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Thrombosis (Thrombus) 12/2017
1	Lymphoma (Lymphomas) 12/2016
1	Glioma (Gliomas) 05/2016
1	Inflammation (Inflammations) 10/2015

Drug/Important Bio-Agent (IBA)

16	MicroRNAs (MicroRNA)IBA 11/2020 - 03/2016
6	Long Noncoding RNAIBA 11/2020 - 08/2016
5	Biological ProductsIBA 01/2022 - 04/2016
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2016
3	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2022 - 05/2016
3	CateninsIBA 12/2019 - 09/2017
3	Small Interfering RNA (siRNA)IBA 10/2019 - 02/2015
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2021 - 09/2018
2	Conditioned Culture MediaIBA 12/2021 - 01/2018
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2021 - 10/2019
2	Transcription Factors (Transcription Factor)IBA 10/2019 - 05/2016
2	Cartilage Oligomeric Matrix ProteinIBA 04/2019 - 09/2018
2	p300-CBP-associated factorIBA 01/2018 - 05/2016
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 03/2016
2	Indicators and Reagents (Reagents)IBA 06/2016 - 05/2015
2	HMGB1 Protein (HMG1)IBA 06/2016 - 10/2015
1	Lysine AcetyltransferasesIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	EnzymesIBA 01/2022
1	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2020
1	RNA (Ribonucleic Acid)IBA 11/2020
1	Prokaryotic Initiation Factor-3IBA 11/2020
1	3' Untranslated Regions (3' UTR)IBA 11/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	histone deacetylase 3IBA 01/2020
1	PeriostinIBA 10/2019
1	Connective Tissue Growth FactorIBA 10/2019
1	TenascinIBA 10/2019
1	platelet-derived growth factor C (PDGF-C)IBA 10/2019
1	Smad Proteins (Mothers Against Decapentaplegic Homolog)IBA 10/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2019
1	Competitive Endogenous RNAIBA 05/2019
1	LipidsIBA 04/2019
1	resolvin D1IBA 04/2019
1	ChromatinIBA 01/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 09/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2018
1	Serine (L-Serine)FDA Link 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Pyruvate KinaseIBA 12/2017
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 12/2017
1	FollistatinIBA 07/2017
1	NADPH Oxidase 4IBA 01/2017
1	NADP (NADPH)IBA 01/2017
1	lymphocyte-specific protein p50IBA 12/2016
1	Untranslated RNA (Noncoding RNA)IBA 05/2016
1	Cyclin D1IBA 04/2016
1	B-Cell Lymphoma 3 ProteinIBA 04/2016
1	Messenger RNA (mRNA)IBA 04/2016
1	Cadherins (E-Cadherin)IBA 02/2016
1	Chromatin Assembly Factor-1IBA 01/2016

Therapy/Procedure

1	Ligation 11/2020
1	Drug Therapy (Chemotherapy) 01/2019
1	Subcutaneous Injections 01/2018
1	Intraperitoneal Injections 01/2018
1	Therapeutics 09/2017